Argent BioPharma has announced that its securities will be placed in a trading halt effective immediately.
The company made the request to the Australian Securities Exchange (ASX) pending the release of an important announcement.
The anticipated announcement is related to a capital raising effort.
The trading halt will remain in place until the earlier of the commencement of normal trading on Tuesday, 2 July 2024, or when the company makes its announcement public.